Medicenna Therapeutics Corp at Cowen Healthcare Conference (Virtual) Transcript
Hello. Welcome to our fireside chat with Medicenna Therapeutics. I have with me President and CEO, Fahar Merchant. Medicenna is developing Superkines as immunotherapy for cancer. Their lead program is in GBM, and then IL-2 program is another key focus.
We'll start with an overview of the company followed by Q&A. So feel free to put any questions you have on the online portal, and we'll get to them at the end of the presentation. And with that, I will hand it over to Fahar.
Well, thank you very much. I'm glad that you could make it to this presentation and fireside chat. Just to let you know, I'll be making forward-looking statements, so I encourage you to look at our regulatory filings for these risk factors, et cetera.
So the company is a Canadian company. We are based out of Toronto but listed both on NASDAQ as well as TSX. The company's focus, really, as was mentioned,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
